BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21837779)

  • 21. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.
    Luckett-Chastain LR; Ihnat MA; Mickle-Kawar BM; Gallucci RM
    J Interferon Cytokine Res; 2012 May; 32(5):207-15. PubMed ID: 22313262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
    Sugaya S; Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
    Chang SW; Yue J; Wang BC; Zhang XL
    Int J Clin Exp Pathol; 2015; 8(10):12853-60. PubMed ID: 26722476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
    Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
    Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
    Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
    Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling.
    Zhang J; Ye Y; Xu Z; Luo M; Wu C; Zhang Y; Lv S; Wei Q
    Biochem Biophys Res Commun; 2023 May; 655():35-43. PubMed ID: 36924677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
    Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
    Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
    Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
    Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
    Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
    Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
    Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of
    Prestel M; Prell-Schicker C; Webb T; Malik R; Lindner B; Ziesch N; Rex-Haffner M; Röh S; Viturawong T; Lehm M; Mokry M; den Ruijter H; Haitjema S; Asare Y; Söllner F; Najafabadi MG; Aherrahrou R; Civelek M; Samani NJ; Mann M; Haffner C; Dichgans M
    Stroke; 2019 Oct; 50(10):2651-2660. PubMed ID: 31500558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3).
    Santerre M; Bagashev A; Gorecki L; Lysek KZ; Wang Y; Shrestha J; Del Carpio-Cano F; Mukerjee R; Sawaya BE
    J Biol Chem; 2019 Mar; 294(10):3618-3633. PubMed ID: 30591585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
    Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
    J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
    McClellan KA; Vanderluit JL; Julian LM; Andrusiak MG; Dugal-Tessier D; Park DS; Slack RS
    Mol Cell Biol; 2009 Sep; 29(17):4701-13. PubMed ID: 19564414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.